Evidence map›Paper›PMID 23382077›Full record

ArticleMolecular and cellular biology2013

The preference for error-free or error-prone postreplication repair in Saccharomyces cerevisiae exposed to low-dose methyl methanesulfonate is cell cycle dependent.

Dongqing Huang, Brian D Piening, Amanda G Paulovich

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Gene-modified embryonic stem cell test to characterize chemical risks.Environmental science and pollution research international · 2015
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Dongqing HuangFred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Brian D Piening
Amanda G Paulovich
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZAFred Hutch Cancer Center · USUniversity of Washington · US

Funding

Phenotype-based approach to find gene interactions underlying breast cancer riskR01CA129604 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PAULOVICH, AMANDA G · 2007 to 2011
$1.3M
NCI NIH HHS R01 CA 129604NCI NIH HHS R01 CA129604
6 · The paper itself

Abstract

Cells employ error-free or error-prone postreplication repair (PRR) processes to tolerate DNA damage. Here, we present a genome-wide screen for sensitivity to 0.001% methyl methanesulfonate (MMS). This relatively low dose is of particular interest because wild-type cells exhibit no discernible phenotypes in response to treatment, yet PRR mutants are unique among repair mutants in their exquisite sensitivity to 0.001% MMS; thus, low-dose MMS treatment provides a distinctive opportunity to study postreplication repair processes. We show that upon exposure to low-dose MMS, a PRR-defective rad18Δ mutant stalls into a lengthy G2 arrest associated with the accumulation of single-stranded DNA (ssDNA) gaps. Consistent with previous results following UV-induced damage, reactivation of Rad18, even after prolonged G2 arrest, restores viability and genome integrity. We further show that PRR pathway preference in 0.001% MMS depends on timing and context; cells preferentially employ the error-free pathway in S phase and do not require MEC1-dependent checkpoint activation for survival. However, when PRR is restricted to the G2 phase, cells utilize REV3-dependent translesion synthesis, which requires a MEC1-dependent delay and results in significant hypermutability.

Indexed as

Cell CycleDNA-Binding ProteinsDNA DamageDNA-Directed DNA PolymeraseDNA, FungalDNA RepairDNA ReplicationG2 Phase Cell Cycle CheckpointsGenome-Wide Association StudyIntracellular Signaling Peptides and ProteinsMethyl MethanesulfonateMutationProtein Serine-Threonine KinasesSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSignal TransductionDNA-Binding ProteinsDNA-Directed DNA PolymeraseDNA, FungalIntracellular Signaling Peptides and ProteinsMEC1 protein, S cerevisiaeMethyl MethanesulfonateProtein Serine-Threonine KinasesRAD18 protein, S cerevisiaeREV3 protein, S cerevisiaeSaccharomyces cerevisiae Proteins

Identifiers

PMID23382077
PMCPMC3624245
OpenAlexW1996315247

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.